A double-blind crossover trial of baclofen--a new treatment for the unstable bladder syndrome.

Forty patients with the unstable bladder syndrome have been treated in a double-blind crossover trial of baclofen 5 mg qds versus placebo. Baclofen significantly improved diurnal and nocturnal frequency of micturition and the severity of incontinence. Considerable improvement was also obtained with placebo.

RCT Entities:   Population Interventions Outcomes